Patents
Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
09/2008
09/04/2008US20080213245 Administering glutenase to Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides; gene therapy
09/04/2008CA2679185A1 2,2,2-tri-substituted acetamide derivatives as glucokinase activators, their process and pharmaceutical application
09/03/2008EP1963280A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators
09/03/2008EP1962852A2 Compounds, compositions and methods
09/03/2008EP1962838A2 Farnesoid x receptor agonists
09/03/2008EP1704143B1 Malononitrile compound as pesticides
09/03/2008CN101255117A Non-steroidal antiphlogiston prodrug with nitric oxide donor and preparation method thereof
09/02/2008US7420089 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition
09/02/2008US7420061 Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors
09/02/2008US7420001 N-({4'-[(1-benzofuran-2-ylcarbonyl)amino]-1,1'-biphenyl-4-yl}sulfonyl)glycine; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis
09/02/2008US7419986 Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans
09/02/2008CA2273023C Aminoguanidines and alkoxyguanidines as protease inhibitors
08/2008
08/28/2008WO2008102908A1 Haloalkylsulfonanilide derivative
08/28/2008US20080207701 Opioid receptor antagonists
08/28/2008US20080207696 Phenacyl 2-Hydroxy-3-Diaminoalkanes
08/28/2008US20080207636 Using a benzmide compound; antidiabetic agents; obesity
08/27/2008EP1960352A1 2-adamantylurea derivatives as selective 11beta-hsd1 inhibitors
08/27/2008EP1959944A1 A pharmaceutical composition comprising an amide derivative
08/27/2008EP1799636B1 Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives
08/27/2008CN100413859C Sulfonated amino acid derivatives and metalloproteinase inhibitors containing same
08/21/2008US20080200525 Pesticidally active ketone and oxime derivatives
08/20/2008EP1569647B1 Cyclohexyl compounds as ccr5 antagonists
08/20/2008EP1249233B1 Npyy5 antagonists
08/19/2008US7414134 B1 bradykinin receptor antagonists
08/19/2008US7414132 prophylaxis and treatment of obesity; secondary amines such as 6-{4-[(3-Methyl-butylamino)-methyl]-phenoxy}-nicotinimidic acid ethyl ester
08/19/2008US7414048 4,5-dihydro-isoxazole derivatives and their pharmaceutical use
08/14/2008WO2008095689A1 Heterocyclyl substituted tetrahydronaphthalene derivatives as 5-ht7 receptor ligands
08/14/2008WO2008019292A3 Compositions and methods for potentiating antibiotic activity
08/14/2008US20080194659 Cinnamic, Phenylpropiolic and Phenylpropanoic Acid Derivatives Useful as Anti-Tumor Agents
08/14/2008US20080194588 Modulation of pathogcnicity
08/14/2008US20080194586 Controlling non-insulin dependent diabetes; hypoglycemic agents; antilipemic agents; hypercholesterolemia; obesity
08/14/2008CA2677437A1 Heterocyclyl substituted tetrahydronaphthalene derivatives as 5-ht7 receptor ligands
08/14/2008CA2578559A1 Process for the preparation of zonisamide and the intermediates thereof
08/13/2008EP1954681A2 Compounds and methods for thiol-containing compound efflux and cancer treatment
08/13/2008CN100410244C Application of isoxazole compounds as bactericide
08/12/2008US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
08/12/2008US7411001 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
08/12/2008US7410971 1,2-di(cyclic)substituted benzene compounds
08/12/2008CA2188228C Use of isoxazole and crotonamide derivatives for the treatment of carcinomatous disorders
08/07/2008WO2008036642A3 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
08/07/2008US20080188529 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders
08/07/2008US20080188489 Cell differentiation inducer
08/07/2008US20080188453 Mapk/erk kinase inhibitors
08/06/2008EP1951719A2 Certain chemical entities, compositions, and methods
08/06/2008EP1439169B1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor
08/06/2008EP1311475B1 Aminocyclohexane derivatives
08/06/2008CN100408539C Vitamin d receptor modulators
08/05/2008US7407950 N-(heteroaryl)-1H-indole-2-carboxamide derivatives and their use as vanilloid TRPV1 receptor ligands
07/2008
07/31/2008WO2008057775A3 Heterocyclic amide compounds useful as kinase inhibitors
07/31/2008WO2008036653A3 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
07/31/2008US20080182837 New chemical compounds
07/30/2008EP1950205A1 Method for stabilization of isoxazole compound
07/30/2008EP1948629A1 Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor
07/30/2008EP1948622A1 Tricyclo substituted amides as glucokinase modulators
07/29/2008US7405230 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs
07/24/2008WO2008089459A1 Inhibitors of mek
07/24/2008CA2675358A1 Inhibitors of mek
07/23/2008CN101228139A Substituted benzo[d]isoxazol-3-yl amine compounds as analgesics
07/22/2008US7402601 ADMINISTERING A DRUG CONTAINING N-(4-TRIFLUOROMETHYLphenyl)-5-METHYLISOXAZOLE-4-CARBOXANILIDE or N-(4-TRIFLUOROMETHYLPHENYL)-2-CYANO-3-HYDROXYCROTONAMIDE; antiinflammatory agents, immunomodulators, immunosuppressants
07/22/2008CA2481246C Compounds that modulate ppar activity and methods for their preparation
07/17/2008WO2008084872A1 Hydrazone derivative
07/17/2008US20080171741 e.g. 5-(4-Chlorophenyl)-N-(5-(cyclopropylcarbamoyl)-2-methylphenyl)furan-2-carboxamide; p38 alpha and beta kinase inhibitor; antiinflammatory agent; asthma, inflammatory bowel disease, osteoporosis, psoriasis, graft vs. host rejection, atherosclerosis, multiple myeloma, pain, myocardial ischemia
07/17/2008US20080171692 Substituted amides
07/16/2008EP1942904A2 Cholesteryl ester transfer protein inhibitors
07/16/2008CN101220000A Acyl chloride and sulfonyl chloride derivant, and uses thereof
07/16/2008CN100402509C Method for synthesizing 4, 4-dimethyl-iso-xazole-3-one
07/16/2008CN100402499C 2-iminopyrrolidine derivatives
07/15/2008US7399854 Regents labeled with energy transfer dyes
07/15/2008US7399765 Substituted diazabicycloalkane derivatives
07/10/2008WO2008080455A1 Tetrahydrobenzoisoxazole - and tetrahydroindazole derivatives as modulators of the mitotic motor protein
07/10/2008WO2008036652A3 Amidines as modulators of indoleamine 2,3-dioxygenase
07/10/2008US20080167360 Cycloalkylidene Compounds as Selective Estrogen Receptor Modulators
07/10/2008US20080167356 metabolic syndrome, diabetes, cholestatic liver disease, fibrosis; improved glucose tolerance and decreased insulin resistance; 6-[4-({[3-(2,6-dichlorophenyl)-5-(1-methylethyl)-4-isoxazolyl]methyl}oxy)phenyl]-1-naphthalenecarboxylic acid
07/10/2008CA2673428A1 Tetrahydrobenzoisoxazole and tetrahydroindazole derivatives as modulators of the mitotic motor protein
07/09/2008CN100400540C Isoxazoline derivatives as anti-depressants
07/08/2008US7396850 Pyrazole derivative as PPAR modulator
07/08/2008US7396847 Oxazolidinone and/or isoxazoline as antibacterial agents
07/08/2008US7396843 5′-carbamoyl-1,1′-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
07/08/2008US7396838 antitumor, anticarcinogenic agents; cytotoxic activity and angiogensis inhibitors; leukemia, colorectal cancer; orally
07/03/2008WO2008078674A1 Glucokinase-activating substance
07/03/2008WO2008077625A1 Heterocyclyl-substituted-ehylamino-phenyl derivatives, their preparation and use as medicaments
07/03/2008WO2008077188A1 Bicyclic pyrimidinones and uses thereof
07/03/2008WO2003068170A3 Enzyme treatment of foodstuffs for celiac sprue
07/03/2008US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome
07/03/2008CA2673601A1 Heterocyclyl-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments
07/03/2008CA2673466A1 Substituted tetracycline compounds
07/03/2008CA2673183A1 Bicyclic pyrimidinones and uses thereof
07/03/2008CA2672088A1 Glucokinase activator
07/02/2008EP1937631A2 Hiv-1 protease inhibitors
07/02/2008EP1692127B1 Triphenylethylene compounds as selective estrogen receptor modulators
07/02/2008EP1496838A4 Substituted amides
07/02/2008CN101213181A Method for producing 3-arylmethylthio--4,5-dihydro-isoxazoline derivative and 3-heteroarylmethylthio-4,5-dihydro-isoxazoline derivative
07/02/2008CN101209974A Hydroxamic acids derivatives and use thereof
07/02/2008CN100398536C Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
07/02/2008CN100398516C Synthesis of taxol enhancers
07/01/2008US7393960 peroxisome proliferator activated receptor agonist such as (2R)-2-(3-{[3-(4-chlorophenoxy)-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl]methyl}phenoxy)butanoic acid, used for treatment and control of metabilic disorders
07/01/2008US7393873 Arylsulfonamide derivatives
06/2008
06/26/2008US20080153892 1-(Urea-, thiourea- and cyanoguanidine-methylene)benzyl)imidaoles, treatment of neuronal disorders, especially Alzheimer's disease, Down Syndrome, Parkinson's disease and Huntington's disease
06/26/2008US20080153890 Phosphinic Amino Acid Compounds
06/26/2008US20080153838 Compounds Having Tie2 (Tek) Activity
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 115